New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 17, 2012
10:27 EDTSJM, RP, UPL, VLO, ITRI, AIMC, HFC, MHS, ARTC, JWN, MXWL, ACOR, DELL, HSPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Dell (DELL) downgraded to Neutral from Outperform at RW Baird...Maxwell Tech (MXWL) downgraded to Neutral from Outperform at RW Baird...Hospira (HSP) downgraded to Sell from Neutral at Citigroup...Acorda Therapeutics (ACOR) downgraded to Neutral from Buy at Citigroup...Nordstrom (JWN) downgraded to Underperform from Buy at CLSA...ArthroCare (ARTC) downgraded to Hold from Buy at Jefferies...Altra Holdings (AIMC) downgraded to Hold from Buy at Jefferies...Ultra Petroleum (UPL) downgraded to Hold from Buy at Jefferies...Medco Health (MHS) downgraded to Equal Weight from Overweight at Morgan Stanley...Itron (ITRI) downgraded to Hold from Buy at KeyBanc...RealPage (RP) downgraded to Sector Perform from Outperform at Pacific Crest...HollyFrontier (HFC) downgraded to Neutral from Buy at UBS...Valero Energy (VLO) downgraded to Neutral from Buy at UBS...J.M. Smucker (SJM) downgraded to Buy from Conviction Buy at Goldman.
News For DELL;MXWL;HSP;ACOR;JWN;ARTC;AIMC;UPL;MHS;ITRI;RP;HFC;VLO;SJM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
February 19, 2015
09:59 EDTAIMCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:59 EDTVLOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Altisource Residential (RESI) upgraded to Neutral from Sell at Compass Point... Angie's List (ANGI) upgraded to Overweight from Equal-Weight at First Analysis... Barrick Gold (ABX) upgraded to Buy from Hold at TD Securities... British Land (BTLCY) upgraded to Buy from Hold at Societe Generale... Coach (COH) upgraded to Buy from Hold at Topeka... Fiat Chrysler (FCAU) upgraded to Outperform from Neutral at Exane BNP Paribas... Garmin (GRMN) upgraded at BofA/Merrill... Hologic (HOLX) upgraded to Buy from Hold at Canaccord... Iberdrola (IBDRY) upgraded to Neutral from Underweight at HSBC... KPN (KKPNY) upgraded to Neutral from Underperform at Exane BNP Paribas... Monster Worldwide (MWW) upgraded at Evercore ISI... Pharmacyclics (PCYC) upgraded to Buy from Neutral at Nomura... RPC, Inc. (RES) upgraded to Equal Weight from Underweight at Morgan Stanley... Sanofi (SNY) upgraded to Buy from Neutral at BofA/Merrill... Sasol (SSL) upgraded to Neutral from Underweight at HSBC... Tractor Supply (TSCO) upgraded at Oppenheimer... Valero (VLO) upgraded to Buy from Hold at Deutsche Bank... Weingarten Realty (WRI) upgraded to Neutral from Sell at UBS... Werner (WERN) upgraded on improving freight fundamentals at RBC Capital... diaDexus (DDXS) upgraded to Buy from Neutral at Ladenburg,
07:47 EDTUPLUltra Petroleum reports FY15 proved reserves up 49% to 5.4 Tcfe
Subscribe for More Information
07:44 EDTUPLUltra Petroleum sees FY15 production up 12% to 275Bcfe–285 Bcfe
Sees FY15 CapEx $460.0M vs. $1.5B in 2014, consisting of $410M in development drilling, $15M in infrastructure and $35M in corporate expenses.
07:41 EDTUPLUltra Petroleum reports Q4 adjusted EPS 62c, consensus 51c
Subscribe for More Information
07:24 EDTAIMCAltra Holdings downgraded to Equal Weight from Overweight at Stephens
Subscribe for More Information
06:30 EDTVLOValero upgraded to Buy from Hold at Deutsche Bank
Subscribe for More Information
06:17 EDTHSPHospira Inflectra patient registry reports interim results in treatment of IBD
Data have been presented on the use of Hospira's Inflectra, the world's first approved biosimilar monoclonal antibody, or mAb, at the European Crohn's and Colitis Organisation Inflammatory Bowel Diseases, or ECCO-ibd, conference. Results show a comparable response in patients treated with Inflectra to that expected with the reference product, Remicade, for inducing and maintaining remission in Crohn's disease, or CD, and ulcerative colitis, or UC. These data add to the body of evidence supporting Inflectra's use in inflammatory bowel disease, or IBD. Results presented from the ongoing independent, prospective, nationwide study in Hungary show that for the first 90 patients, treated with Inflectra, reductions compared with baseline were seen in validated measures of disease activity after both two and six weeks of treatment. C-reactive protein, or CRP, a marker of inflammation, was also decreased during induction therapy for UC. Four of the 90 patients showed an allergic reaction to treatment, all of who had previously received anti-TNF medication. The abstract can be found at: P314 Biosimilar infliximab in inflammatory bowel diseases: first interim results from a prospective nationwide observational cohort.
February 18, 2015
16:32 EDTAIMCAltra Holdings sees FY15 adjusted EPS $1.65-$1.85, consensus $2.00
Subscribe for More Information
16:30 EDTAIMCAltra Holdings reports Q4 adjusted EPS 42c, consensus 38c
Subscribe for More Information
10:05 EDTVLOOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Agnico Eagle (AEM) upgraded to Overweight from Neutral at JPMorgan... Amarin (AMRN) upgraded to Buy from Neutral at SunTrust... Capital Product (CPLP) upgraded to Accumulate from Neutral at Global Hunter... Carlyle Group (CG) upgraded to Buy from Neutral at Citigroup... Danone (DANOY) upgraded to Neutral from Underperform at Exane BNP Paribas... Express (EXPR) upgraded on lower promotional activity at Piper Jaffray... Kforce (KFRC) upgraded to Outperform from Market Perform at Avondale... Legg Mason (LM) upgraded to Buy from Hold at Jefferies... Rackspace (RAX) upgraded following Q4 results at Pacific Crest... Rosetta Resources (ROSE) upgraded to Buy from Neutral at Global Hunter... SeaChange (SEAC) upgraded to Buy from Hold at Noble Financial... Valero (VLO) upgraded to Outperform from Neutral at Credit Suisse... Veeco (VECO) upgraded to Buy from Hold at Noble Financial... Wolverine World Wide (WWW) upgraded to Neutral from Underperform at Sterne Agee.
08:41 EDTHSPThe Medicines Co. says not giving financial guidance due to Hospira suit
Subscribe for More Information
06:12 EDTVLOValero upgraded to Outperform from Neutral at Credit Suisse
Subscribe for More Information
February 17, 2015
17:13 EDTVLOPoint72 gives quarterly update on stakes
Subscribe for More Information
15:54 EDTSJMJ.M. Smucker targets long-term EPS growth of 8% plus
Targets long term organic growth 3%-4%.
15:51 EDTSJMJ.M. Smucker share repurchase activity on hold in near time
Subscribe for More Information
10:00 EDTJWNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:15 EDTSJMConsumer Analyst Group of New York (CAGNY) to hold a conference
Subscribe for More Information
04:58 EDTJWNNordstrom downgraded to Underweight from Equal Weight at Barclays
Subscribe for More Information
04:47 EDTHSPPfenex price target raised to $16 from $12 at Mizuho
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use